In Vitro Effects of Different Probiotic Mouthwash Formulations on the Growth of Oral Pathogens
Objectives: To investigate the effect of various probiotic mouthwash formulations on the quantity of oral pathogenic microorganisms.
Methods: This was a laboratory-based study testing four different mouthwash formulations: (1) 10% probiotic supernatant mouthwash, (2) 10% probiotic supernatant / 5% propolis mouthwash, (3) 10% probiotic supernatant / 1% cannabidiol mouthwash, and (4) 10% probiotic supernatant / 5% propolis / 1% cannabidiol mouthwash. A positive control (chlorhexidine mouthwash) and a negative control (0.9% saline solution) were also included. The inhibitory efficacy of these formulations was tested against two microorganisms: Candida albicans and Streptococcus mutans. Quantitative data were collected by counting colonies before and after treatment (CFU/mL). Descriptive statistics and One way ANOVA test were used for analysis (p<0.05).
Results: The results showed that each mouthwash formulation could inhibit both pathogenic microorganisms to varying degrees, with a greater effect observed on Streptococcus mutans than on Candida albicans. When the quantitative data from colony counts were subjected to statistical analysis, no statistically significant differences were found among the mouthwash formulations (p>0.05) in inhibiting both types of microorganisms. Notably, the mouthwash containing 10% probiotic supernatant, 5% propolis and 1% cannabidiol demonstrated a statistically significant inhibitory effect on Streptococcus mutans (p<0.05).
Conclusions: All four mouthwash formulations showed a tendency to inhibit both pathogenic microorganisms, although this was not statistically significant in all cases. The formulation containing 10% probiotic supernatant, 5% propolis, and 1% cannabidiol had the most favorable effect in inhibiting the cariogenic bacterium Streptococcus mutans.
References
1. Chugh P, Dutt R, Sharma A, Bhagat N, Dhar MS. A critical appraisal of the effects of probiotics on oral health. J Funct Foods. 2020;70:103985.
2. Maier T. Oral microbiome in health and disease: Maintaining a healthy, balanced ecosystem and reversing dysbiosis. Microorganisms. 2023;11(6):1453.
3. Huovinen P. Bacteriotherapy: the time has come. BMJ. 2001;323(7309):353-4.
4. Mohd Fuad AS, Amran NA, Nasruddin NS, Burhanudin NA, Dashper S, Arzmi MH. The mechanisms of probiotics, prebiotics, synbiotics, and postbiotics in oral cancer management. Probiotics Antimicrob Proteins. 2023;15(5):1298-311.
5. Homayouni Rad A, Pourjafar H, Mirzakhani E. A comprehensive review of the application of probiotics and postbiotics in oral health. Front Cell Infect Microbiol. 2023;13:1009606.
6. Vincenzi A, Goettert MI, Volken de Souza CF. An evaluation of the effects of probiotics on tumoral necrosis factor (TNF-α) signaling and gene expression. Cytokine Growth Factor Rev. 2021;57:27-38.
7. Ladda B, Theparee T, Chimchang J, Tanasupawat S, Taweechotipatr M. In vitro modulation of tumor necrosis factor α production in THP-1 cells by lactic acid bacteria isolated from healthy human infants. Anaerobe. 2015;33:109-16.
8. Banjonjit S, Taweechotipatr M, Rungsiyanont S. Effect of probiotic Lactobacillus paracasei on tumor necrosis factor-alpha level in gingival crevicular fluid of patients undergoing impacted third molar removal. J Oral Sci. 2022;64(3):185-9.
9. Wu CC, Lin CT, Wu CY, Peng WS, Lee MJ, Tsai YC. Inhibitory effect of Lactobacillus salivarius on Streptococcus mutans biofilm formation. Microb Pathog. 2018;121:258-64.
10. Cotter PD, Hill C, Ross RP. Bacteriocins: Developing innate immunity for food. Nat Rev Microbiol. 2005;3(10):777-88.
11. Darbandi A, Asadi A, Mahdizade Ari M, Ohadi E, Talebi M, Halaj Zadeh M, et al. Bacteriocins: properties and potential use as antimicrobials. J Clin Lab Anal. 2022;36(1):e24093.
12. Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 2009;1(7):1333-49.
13. Lowe H, Toyang N, Steele B, Bryant J, Ngwa W, Nedamat K. The current and potential application of medicinal cannabis products in dentistry. Dent J (Basel). 2021;9(9):106.
14. Vasudevan K, Stahl V. Cannabinoids infused mouthwash products are as effective as chlorhexidine on inhibition of total-culturable bacterial content in dental plaque samples. J Cannabis Res. 2020;2(1):20. doi: 10.1186/s42238-020-00027-z.
15. Ercan N, Erdemir EO, Ozkan SY, Hendek MK. The comparative effect of propolis in two different vehicles; mouthwash and chewing-gum on plaque accumulation and gingival inflammation. Eur J Dent. 2015;9(2):272-6.
16. Nisapa N, Taweechotipatr M, Rungsiyanont S. The development of probiotic mouthwash formulation with cannabis extracts on the reduction of proinflammatory cytokine: TNF-alpha level. In: The 13th Hatyai National and International Conference; 2022 Dec 1-3; Hatyai, Thailand. Hatyai University; 2022. p. 848-61.
17. Zulhendri F, Lesmana R, Tandean S, Christoper A, Chandrasekaran K, Irsyam I, et al. Recent update on the anti-inflammatory activities of propolis. Molecules. 2022;27(23):8473.
18. Zulhendri F, Felitti R, Fearnley J, Ravalia M. The use of propolis in dentistry, oral health, and medicine: a review. J Oral Biosci. 2021;63(1):23-34.
19. Magro-Filho O, de Carvalho AC. Topical effect of propolis in the repair of sulcoplasties by the modified Kazanjian technique. cytological and clinical evaluation. J Nihon Univ Sch Dent. 1994;36(2):102-11.
20. Suetrongtrakool N, Taweechotipatr M, Rungsiyanont S. Effectiveness of probiotic mouthwash containing cannabis extracts and propolis on the reduction of tumor necrosis factor-alpha inflammatory cytokine. Procedia Multidiscip Res. 2023;1(7):484-90.
21. Chen X, Daliri EB, Kim N, Kim JR, Yoo D, Oh DH. Microbial etiology and prevention of dental caries: exploiting natural products to inhibit cariogenic biofilms. Pathogens. 2020;9(7):531.
22. Peterson SN, Snesrud E, Liu J, Ong AC, Kilian M, Schork NJ, et al. The dental plaque microbiome in health and disease. PLoS One. 2013;8(3):e58487.
23. Peres MA, Macpherson LMD, Weyant RJ, Daly B, Venturelli R, Mathur MR, et al. Oral diseases: a global public health challenge. Lancet. 2019;394(10194):249-60.
24. Phillips TR, Fairley CK, Maddaford K, Trumpour S, Wigan R, Bradshaw CS, et al. Duration of gargling and rinsing among frequent mouthwash users: a cross-sectional study. BMJ Open. 2020;10(9):e040754. doi: 10.1136/bmjopen-2020-040754.
25. Rossoni RD, Velloso MDS, de Barros PP, de Alvarenga JA, Santos JDD, Santos Prado ACCD, et al. Inhibitory effect of probiotic lactobacillus supernatants from the oral cavity on Streptococcus mutans biofilms. Microb Pathog. 2018;123:361-7.
26. Lin X, Chen X, Chen Y, Jiang W, Chen H. The effect of five probiotic lactobacilli strains on the growth and biofilm formation of Streptococcus mutans. Oral Dis. 2014;20(4):e128-34.
27. van Swaaij BWM, Slot DE, Van der Weijden GA, Timmerman MF, Ruben J. Fluoride, pH value, and titratable acidity of commercially available mouthwashes. Int Dent J. 2024;74(2):260-7.